Read More Analyst Ratings News Price Target Mizuho Maintains Buy on Boston Properties, Lowers Price Target to $105 By Benzinga Newsdesk July 6, 8:12 AM Mizuho analyst Vikram Malhotra maintains Boston Properties (NYSE:BXP) with a Buy and lowers the price target from $135 to $105. BXP
Read More Markets News Pre-Market Outlook Trading Ideas US Stocks Record Third Consecutive Weekly Loss But Market Volatility Decreases By Lisa Levin September 6, 4:06 AM U.S. equity markets ended the trading week on a negative note despite better-than-expected data on nonfarm payrolls. AAPL
Read More Biotech General News Aerovate Therapeutics To Present Patient Baseline Characteristics Of The Phase 2b Portion Of The Phase 2b/Phase 3 IMPAHCT Trial At The American Thoracic Society 2024 International Conference By Benzinga Newsdesk March 27, 9:28 AM Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease, today announced an upcoming poster AVTE
Read More Contracts Equities Markets News BAE Systems Secures £3.95B Funding For Next Phase Of AUKUS Submarine Program By Akanksha Bakshi October 2, 6:56 AM BAE Systems plc (OTC: BAESY) (OTC: BAESF) has BAESF